these results suggest that ad-4610 selectively potentiates glucose-induced insulin secretion by increasing the sensitivity of pancreatic b-cells to glucose and may be useful for treating human niddm through a different mechanism than that of tolbutamide .
C0011860
niddm
C0040374
tolbutamide